Rhenman & Partners Asset Management AB - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$2,009,100
-49.1%
370,0000.0%0.21%
-49.2%
Q3 2022$3,944,000
+152.5%
370,000
+17.0%
0.41%
+133.3%
Q2 2022$1,562,000
-35.0%
316,1370.0%0.18%
-25.3%
Q1 2022$2,403,000
-29.3%
316,137
-2.7%
0.24%
+4.9%
Q4 2021$3,400,000
-22.1%
325,0000.0%0.23%
-26.1%
Q3 2021$4,362,000
-38.8%
325,0000.0%0.31%
-36.8%
Q2 2021$7,131,000
-8.8%
325,0000.0%0.48%
-11.2%
Q1 2021$7,820,000
+81.1%
325,000
+35.4%
0.54%
+54.8%
Q4 2020$4,318,000
+96.7%
240,000
+26.3%
0.35%
+80.5%
Q3 2020$2,195,000
-52.4%
190,0000.0%0.20%
-60.8%
Q2 2020$4,609,000
+67.2%
190,000
-24.1%
0.50%
+29.0%
Q1 2020$2,757,000
-60.4%
250,172
-5.0%
0.39%
-49.4%
Q4 2019$6,962,000
-42.9%
263,400
-50.8%
0.76%
-50.1%
Q3 2019$12,202,000
+45.1%
535,657
+95.3%
1.53%
+65.2%
Q2 2019$8,409,000
+138.8%
274,274
+29.3%
0.93%
+124.8%
Q1 2019$3,522,000
+6.4%
212,169
+22.8%
0.41%
+9.0%
Q4 2018$3,310,000172,8200.38%
Other shareholders
G1 THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
MPM BioImpact LLC 650,000$3,529,5000.92%
CHI Advisors LLC 333,945$1,813,3210.48%
PVG ASSET MANAGEMENT CORP 15,585$84,6260.37%
Rhenman & Partners Asset Management AB 370,000$2,009,1000.21%
NEEDHAM INVESTMENT MANAGEMENT LLC 184,000$999,1200.18%
Birchview Capital, LP 40,000$2170.15%
XTX Topco Ltd 102,282$555,3910.12%
Tekla Capital Management LLC 423,869$2,301,6090.09%
Woodline Partners LP 1,028,967$5,587,2910.08%
Curi Wealth Management, LLC 81,009$439,8790.06%
View complete list of G1 THERAPEUTICS INC shareholders